Emily Woodworth's most recent trade in Boston Scientific Corp. was a trade of 7,149 Common Stock done at an average price of $105.0 . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Boston Scientific | Emily M. Woodworth | SVP, Global Controller and CAO | Sale of securities on an exchange or to another person at price $ 104.97 per share. | 03 Mar 2025 | 7,149 | 914 (0%) | 0% | 105.0 | 750,465 | Common Stock |
| Boston Scientific | Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.50 per share. | 03 Mar 2025 | 5,949 | 8,063 (0%) | 0% | 37.5 | 223,088 | Common Stock |
| Boston Scientific | Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 5,949 | 2,383 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Emily M. Woodworth | SVP, Global Controller and CAO | Sale of securities on an exchange or to another person at price $ 104.63 per share. | 03 Mar 2025 | 482 | 432 (0%) | 0% | 104.6 | 50,432 | Common Stock |
| Boston Scientific | Emily M. Woodworth | SVP, Global Controller and CAO | Sale of securities on an exchange or to another person at price $ 101.13 per share. | 28 Feb 2025 | 9,887 | 1,632 (0%) | 0% | 101.1 | 999,872 | Common Stock |
| Boston Scientific | Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.16 per share. | 28 Feb 2025 | 7,218 | 11,519 (0%) | 0% | 42.2 | 304,311 | Common Stock |
| Boston Scientific | Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 7,218 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 837 | 2,514 | - | - | Restricted Stock Units | |
| Boston Scientific | Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 837 | 2,469 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Emily M. Woodworth | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.79 per share. | 28 Feb 2025 | 355 | 2,114 (0%) | 0% | 103.8 | 36,845 | Common Stock |
| Boston Scientific | Emily Woodworth M. | SVP, Global Controller and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 5,732 | 5,732 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Emily Woodworth M. | SVP, Global Controller and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 5,652 | 5,652 | - | - | Restricted Stock Units | |
| Boston Scientific | Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 667 | 0 | - | - | Restricted Stock Units | |
| Boston Scientific | Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 667 | 4,584 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 661 | 1,322 | - | - | Restricted Stock Units | |
| Boston Scientific | Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 661 | 3,867 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 636 | 637 | - | - | Restricted Stock Units | |
| Boston Scientific | Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 636 | 4,188 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Emily Woodworth M. | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 315 | 3,552 (0%) | 0% | 106.1 | 33,425 | Common Stock |
| Boston Scientific | Emily Woodworth M. | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 283 | 4,301 (0%) | 0% | 106.1 | 30,029 | Common Stock |
| Boston Scientific | Emily Woodworth M. | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 271 | 3,917 (0%) | 0% | 106.1 | 28,756 | Common Stock |
| Boston Scientific | Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 480 | 1,443 | - | - | Restricted Stock Units | |
| Boston Scientific | Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 480 | 3,437 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Emily Woodworth M. | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 231 | 3,206 (0%) | 0% | 105.8 | 24,433 | Common Stock |
| Boston Scientific | Emily Woodworth | SVP, Global Controller and CAO | 27 Nov 2024 | 1,336 | 2,957 (0%) | 0% | 90.6 | 121,105 | Common Stock | |
| Boston Scientific | Emily Woodworth | SVP, Global Controller and CAO | 01 Mar 2024 | 3,421 | 3,421 | - | - | Stock Option (Right to Buy) | ||
| Boston Scientific | Emily Woodworth | SVP, Global Controller and CAO | 01 Mar 2024 | 3,351 | 3,351 | - | - | Restricted Stock Units |